News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
UPDATE 1-New WHO guidance calls for more evidence on airborne transmission
(Adds details on guidelines, scientist comment) By Julie Steenhuysen (Reuters) - The World Health Organization on Thursday released new guidelines on the transmission of the novel coronavirus that
Blood test may diagnose concussions, severity of brain injury
By Linda Carroll (Reuters Health) - A biomarker that can be found in both spinal fluid and blood may offer a way to accurately diagnose concussions and their severity as well as show when the brain
Decreased endovascular therapy of stroke during COVID-19 lockdowns
By Will Boggs MD NEW YORK (Reuters Health) - Stay-at-home orders during the COVID-19 pandemic have been associated with reduced endovascular therapy of acute stroke and with increased times to
Elderly may under-report fractured rib pain
By David Douglas NEW YORK (Reuters Health) - Although it's unclear whether geriatric patients with rib fractures feel less pain than their younger counterparts, reported pain scores are generally
Milk, sodas, sugary and fatty foods tied to adult acne
By Lisa Rappaport (Reuters Health) - Fatty and sugary foods, sugar-sweetened beverages, and milk consumption are all associated with an increased risk of adult acne, a recent study suggests.
ACE inhibitors and ARBs do not increase risk of severe/lethal COVID-19
By Will Boggs MD NEW YORK (Reuters Health) - Angiotensin converting-enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) do not increase the risk of severe or lethal COVID-19, according to
Lockdown in Denmark linked to drop in new AF diagnoses
By Anne Harding NEW YORK (Reuters Health) - The incidence of new-onset atrial fibrillation (AF) fell by nearly half during the first three weeks of Denmark's COVID-19 lockdown, new findings in the
New neurological symptoms, brain lesions may occur in severe pediatric COVID-19
By Marilynn Larkin NEW YORK (Reuters Health) - Children with COVID-19 may present with new neurological symptoms, as well as splenial lesions in the corpus callosum on imaging, but no respiratory
REFILE-Car seat tolerance screen performance varies in U.S. newborn nurseries
(Removes repeated journal name in paragraph 15) By Lisa Rappaport (Reuters Health) - Newborn nurseries in the U.S. vary in their implementation and inclusion criteria for car seat-tolerance screening,
Car seat tolerance screen performance varies in U.S. newborn nurseries
By Lisa Rappaport (Reuters Health) - Newborn nurseries in the U.S. vary in their implementation and inclusion criteria for car seat-tolerance screening, a new study suggests. Researchers surveyed a
COVID-19 status should influence noninfectious uveitis treatment decisions
By Reuters Staff NEW YORK (Reuters Health) - In patients with noninfectious uveitis, the individual's COVID-19 status should influence decisions regarding immunomodulatory therapy (IMT), according to
Prolonged ketosis in hyperglycemic emergencies seen with COVID-19
By Reuters Staff NEW YORK (Reuters Health) - COVID-19 may lead to hyperglycemic emergencies and protracted ketonemia in patients with diabetes, according to a case series from the UK. Diabetes has
Veteran female leaders to head WHO COVID-19 review amid anti-globalism barbs
By John Miller ZURICH (Reuters) - Avowed multilateralists Ellen Johnson Sirleaf and Helen Clark will lead a World Health Organization (WHO) panel scrutinising the global response to the COVID-19
EU lawmakers urge Japan to end parental child "abductions"
By Marine Strauss and Chang-Ran Kim BRUSSELS/TOKYO (Reuters) - The European Parliament urged Japan to comply with international rules on child protection and to allow for joint parental custody after
Brazil press group files criminal complaint against Bolsonaro for removing mask
By Reuters Staff RIO DE JANEIRO (Reuters) - The Brazilian Press Association on Thursday filed a criminal complaint to the Supreme Court against President Jair Bolsonaro, after he took off his mask in
UPDATE 1-WHO sets up panel to review handling of COVID-19 pandemic
(Adds comments by senior U.S. official, global health law expert) By Stephanie Nebehay and John Miller GENEVA/ZURICH (Reuters) - The World Health Organization (WHO) said on Thursday it was setting up
New WHO guidance calls for more evidence on airborne transmission
By Julie Steenhuysen (Reuters) - The World Health Organization on Thursday released new guidelines on the transmission of the novel coronavirus that acknowledge some reports of airborne transmission
SPECIAL REPORT-Bolsonaro bets 'miraculous cure' for COVID-19 can save Brazil - and his life
By Gabriel Stargardter and Lisandra Paraguassu RIO DE JANEIRO/BRASILIA (Reuters) - Brazilian President Jair Bolsonaro has gone all in on hydroxychloroquine to help his coronavirus-ravaged country beat
New $1 bln fund aims to steer antibiotic companies in tough market
By Manas Mishra (Reuters) - A new $1 billion fund backed by 20 drugmakers including Merck & Co Inc and Pfizer Inc is aiming to bolster struggling antibiotic companies and sustain a pipeline for new
With apps and remote medicine, Japan offers glimpse of doctor visits in post-corona era
By Kaori Kaneko and Izumi Nakagawa TOKYO (Reuters) - The coronavirus crisis has prompted Japan to ease regulations on remote medical treatment, creating an opening for tech companies and offering a
EU raises its bet on blood plasma in search for COVID-19 therapy
By Francesco Guarascio BRUSSELS (Reuters) - The European Union wants to fast-track funding to treat COVID-19 patients with blood plasma collected from survivors, an EU document seen by Reuters shows,
Africa urged to test more as coronavirus cases exceed 500,000
By George Obulutsa NAIROBI (Reuters) - African countries must carry out more coronavirus testing and make people use masks, a regional disease control body said on Thursday as cases topped half a
WHO sets up panel to review handling of COVID-19 pandemic
By Stephanie Nebehay and John Miller GENEVA/ZURICH (Reuters) - The World Health Organization (WHO) said on Thursday it was setting up an independent panel to review its handling of the COVID-19
South Korea finds just one case of coronavirus antibodies out of 3,000 tested
By Reuters Staff SEOUL (Reuters) - Just one person in a South Korean survey of more than 3,000 people showed neutralizing antibodies to the novel coronavirus, health authorities said on Thursday,
Co-testing with Pap, HPV tests more likely to detect cervical cancer, precancer
By Marilynn Larkin NEW YORK (Reuters Health) - Human papilloma virus (HPV) or Papanicolaou test by liquid-based cytology (LBC) alone are less likely to detect cervical cancer or precancer (neoplasia
COVID-19 convalescent plasma donors reach higher levels of IgG four weeks after symptom onset
By Linda Carroll (Reuters Health) - IgG in COVID-19 convalescent plasma donors appears to reach higher levels four weeks following onset of symptoms, suggesting that's the optimal time to collect
Injectable experimental antibody relieves pruritus caused by atopic dermatitis
By Gene Emery (Reuters Health) - Subcutaneous abdominal injections of the experimental monoclonal antibody nemolizumab produced significant improvement in patients with atopic dermatitis and
KRASG12C-mutant NSCLC likely smoking-related, targetable by brain metastasis therapies
By Marilynn Larkin NEW YORK (Reuters Health) - KRASG12C- mutant non-small-cell lung cancer (NSCLC) appears to be smoking-related and is likely targetable by inhibitors that can delay or prevent brain
Flu drug blocks household spread by 86%
By Gene Emery (Reuters Health) - A single dose of the influenza drug baloxavir marboxil, if given quickly to the family members of someone who has developed the flu, can prevent 86% of parents and
Preschooler's month of birth influences odds of becoming ill with the flu
By Gene Emery (Reuters Health) - Preschoolers have a higher risk of being diagnosed with the flu if they are born before September, an analysis of insurance claims from more than 1.1 million children
Lifetime discrimination linked to hypertension in Black Americans
By Anne Harding NEW YORK (Reuters Health) - Racism may help explain the increased risk of hypertension among Black Americans, according to new findings in Hypertension. The amount of discrimination a
Guidance on managing liver dysfunction during COVID-19 pandemic
By Reuters Staff NEW YORK (Reuters Health) - Patients with COVID-19 may develop abnormal liver function and it's important to consider the potential impact of COVID-19 on the liver, especially in the
Skiers have increased risk of distal femoral cortical irregularity
By Lisa Rappaport (Reuters Health) - Youth competitive alpine skiers have a higher prevalence of distal femoral cortical irregularities (DFCIs) than peers outside the sport, a recent study suggests.
Biogen moves forward with potential Alzheimer's drug, seeks U.S. approval
By Manojna Maddipatla (Reuters) - Biogen Inc said on Wednesday it submitted an application seeking U.S. approval of its closely watched Alzheimer's drug, as the company aims to be the first to bring a
New U.S. CDC school reopening guidelines promised after Trump complains
By Doina Chiacu and Daphne Psaledakis WASHINGTON (Reuters) - The U.S. Centers for Disease Control and Prevention plans to issue new guidelines for reopening schools, Vice President Mike Pence said on
Italy to monitor sewage in hunt for possible new COVID-19 wave
By Reuters Staff MILAN (Reuters) - Italy plans to monitor wastewater nationwide for a possible early warning about any renewed outbreak of COVID-19 infections, the National Institute of Health (ISS)
COVID SCIENCE-Virus tricks the body into attacking brain; common heartburn drugs linked to coronavirus risk
By Nancy Lapid (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness
Inhaled dye allows intraoperative visualization of lung-tumor margin
By Will Boggs MD NEW YORK (Reuters Health) - Inhalational indocyanine green (ICG) can be useful for the intraoperative visualization of lung-tumor margin, researchers from South Korea report. Surgical
Rivaroxaban curbs thromboembolic events in patients still ill at discharge
By David Douglas NEW YORK (Reuters Health) - Following hospital discharge, extended-duration thromboprophylaxis with low-dose rivaroxaban cuts the combined risk of fatal and major thromboembolic
Immunosuppressive treatment tied to better outcomes of cerebral amyloid angiopathy-related inflammation
By Will Boggs MD NEW YORK (Reuters Health) - Immunosuppressive treatment is associated with an improved disease course and reduced recurrence rate of cerebral amyloid angiopathy-related inflammation (
Japan supercomputer suggests changes to travel, work amid airborne virus threat
By Rocky Swift TOKYO (Reuters) - Supercomputer-driven models simulated in Japan suggested that operating commuter trains with windows open and limiting the number of passengers may help reduce the
U.S. Supreme Court allows broader religious exemption to birth control coverage
By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Wednesday endorsed a plan by President Donald Trump's administration to give employers broad religious and moral exemptions from a
INSIGHT-In Africa, lack of coronavirus data raises fears of 'silent epidemic'
By Katharine Houreld and David Lewis NAIROBI (Reuters) - When the new coronavirus hit Tanzania in mid-April, President John Magufuli called for three days of national prayer to seek God's protection
EU scrambles to buy intensive care drugs to tackle COVID shortages
By Francesco Guarascio BRUSSELS (Reuters) - The European Union is seeking firms to supply 24 intensive care drugs, an EU official told Reuters, as it strives to tackle shortages of medicines for COVID
Congo virus funds embezzled by 'mafia network', says deputy minister
By Stanis Bujakera and Hereward Holland KINSHASA (Reuters) - Congo's deputy health minister has accused cabinet members of receiving kickbacks on government contracts for the coronavirus response
Criminals cash in on rush to buy coronavirus protective gear, U.N. says
By Reuters Staff VIENNA (Reuters) - A rush by countries to buy personal protective equipment during the coronavirus pandemic has created an opportunity for criminal groups, which are peddling
REFILE-Immigrant physicians in the U.S. may be especially vulnerable depending on visa type
(Removes duplicate "Dr" from para 4.) By Linda Carroll (Reuters Health) - Immigrant physicians working in the U.S. are especially vulnerable during COVID-19 if they are in the country on an H-1B (
REFILE-Some rheumatic diseases tied to higher risk of severe COVID-19
(Fixes typo in para 9 of story originally posted Jun 19) By Megan Brooks NEW YORK (Reuters Health) - Patients with some inflammatory rheumatic conditions are at higher risk for hospital-diagnosed
China could have done more to aid world's COVID-19 response, top U.S. health official says
By Carl O'Donnell (Reuters) - U.S. coronavirus task force response coordinator Dr. Deborah Birx said that the United States and other countries could have had a stronger initial response to COVID-19
U.S. withdrawal from WHO to take effect July 2021 - U.N.
By Reuters Staff WASHINGTON (Reuters) - The United States will leave the World Health Organization on July 6, 2021, the United Nations said on Tuesday after receiving formal notification of the
Parents find 'as-needed' posthospital care for bronchiolitis noninferior to scheduled visits
By Lisa Rappaport (Reuters Health) - Parents of children hospitalized for bronchiolitis find follow-up care on an as-needed basis noninferior to scheduled visits, a clinical trial suggests. The
'Compelling' argument for statins for primary CVD prevention in the elderly
By Megan Brooks NEW YORK (Reuters Health) - A large retrospective study supports statin therapy for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in the elderly. Among U.S.
Off-road screening tests can identify impaired driving among older adults
By Lisa Rappaport (Reuters Health) - Off-road driver screening tests can reliably identify older adults who are likely to fail on-road driving tests, an Australian study suggests. Researchers examined
Immigrant physicians in the U.S. may be especially vulnerable depending on visa type
By Linda Carroll (Reuters Health) - Immigrant physicians working in the U.S. are especially vulnerable during COVID-19 if they are in the country on an H-1B (temporary employment) or J-1 (exchange
Demand for unproven COVID-19 remedy led to shortages for SLE patients
By Reuters Staff NEW YORK (Reuters Health) - Pandemic-driven demand for hydroxychloroquine (HCQ) contributed to shortages of the antimalarial for patients with systemic lupus erythematosus (SLE) in
New curriculum boosts ICU nurses' confidence with ECMO during pandemic
By Marilynn Larkin NEW YORK (Reuters Health) - A standardized curriculum developed specifically to train critical care nurses in extracorporeal membrane oxygenation (ECMO) was rapidly deployed in a
UPDATE 1-Brazil's Bolsonaro catches coronavirus, shrugs off health risks
(Adds comments from Bolsonaro, White House spokeswoman, U.S. embassy) By Ana Mano and Lisandra Paraguassu SAO PAULO/BRASILIA (Reuters) - Brazilian President Jair Bolsonaro said on Tuesday he tested
ACE inhibitors/ARBs lower colorectal cancer risk
By Will Boggs MD NEW YORK (Reuters Health) - The use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) is associated with a lower risk of colorectal cancer
UPDATE 1-WHO acknowledges 'evidence emerging' of airborne spread of COVID-19
(Adds comments from scientist who called for a change in guidance) By Reuters Staff GENEVA (Reuters) - The World Health Organization on Tuesday acknowledged "evidence emerging" of the airborne spread
HHS to open 'surge' COVID-19 testing in Florida, Texas, Louisiana
By Reuters Staff (Reuters) - The U.S. government is creating short-term "surge" testing sites for the novel coronavirus in three metropolitan areas in Florida, Louisiana and Texas to meet demand from
Poor data obscures COVID-19 death toll at Spain's nursing homes
By Belén Carreño and Nathan Allen MADRID (Reuters) - The Spanish government is still not able to say how many nursing home residents have died because of the coronavirus, according to a Health
Hepatotoxicity tied to remdesivir COVID-19 treatment
By David Douglas NEW YORK (Reuters Health) - Although remdesivir treatment may shorten time to recovery in patients with COVID-19, it may also induce liver injury, possibly in combination with
WHO experts to travel to China at weekend to study COVID-19 origins
By Reuters Staff GENEVA (Reuters) - The World Health Organization said on Tuesday that experts from the global body would travel to China at the weekend to prepare a study of the origins of the novel
WHO acknowledges 'evidence emerging' of airborne spread of COVID-19
By Reuters Staff GENEVA (Reuters) - The World Health Organization on Tuesday acknowledged "evidence emerging" of the airborne spread of the novel coronavirus, after a group of scientists urged the
Interventions could reduce racial disparity in neonatal kernicterus
By Will Boggs MD NEW YORK (Reuters Health) - Various interventions could reduce the largely overlooked high kernicterus rate among Black infants, a new review suggests. Black neonates account for
People refusing coronavirus treatment may face jail in Italy's Veneto
By Emilio Parodi MILAN (Reuters) - People who test positive for the coronavirus but refuse hospital treatment could face a prison sentence under a new regulation introduced in Italy's northeastern
Brazil President Bolsonaro tests positive for coronavirus
By Reuters Staff SAO PAULO (Reuters) - Brazilian President Jair Bolsonaro said on Tuesday he tested positive for the novel coronavirus, adding in a television interview that he was in good health
GSK to develop plant-based COVID-19 vaccine with Canada's Medicago
By Reuters Staff (Reuters) - The world's largest vaccine-maker GSK has put its vaccine booster technology to work in a potential new COVID-19 shot, to be developed with a Canadian biopharmaceutical
UPDATE 1-U.S. government awards Novavax $1.6 billion for coronavirus vaccine
(Adds comments from analyst, HHS secretary and Novavax scientist) By Julie Steenhuysen CHICAGO (Reuters) - The U.S. government has awarded Novavax Inc $1.6 billion to cover testing and manufacturing
Congo health workers reduce coronavirus services in pay protest
By Benoit Nyemba KINSHASA (Reuters) - Health workers responding to the coronavirus outbreak in Democratic Republic of Congo's capital have cut their services to a minimum in protest against unpaid
Sierra Leone doctors threaten to expand strike amid COVID-19 crisis
By Cooper Inveen FREETOWN (Reuters) - Doctors in Sierra Leone, who are refusing to treat COVID-19 patients to press demands for bonus payments and more protective equipment, threatened on Tuesday to
South Korean COVID-19 patient recovering after double lung transplant
By Sangmi Cha ANYANG, South Korea (Reuters) - After a record 112 days on a specialised life-support system, a South Korean COVID-19 patient is recovering from double lung transplant surgery, doctors
U.S. signs $450 mln contract with Regeneron for COVID-19 therapy
By Manojna Maddipatla (Reuters) - The U.S. government signed a $450 million contract with Regeneron Pharmaceuticals Inc for its potential COVID-19 antibody cocktail, the drugmaker said on Tuesday. The
GSK says long-acting HIV prevention drug 65% more effective than Truvada
By Reuters Staff (Reuters) - Britain's GSK said on Tuesday that an injection of its cabotegravir drug given every two months was found to be 65% more effective in preventing HIV infections than
Case of HIV patient in remission raises hopes
By Kate Kelland LONDON (Reuters) - A first case of an HIV-positive man who went into long-term remission after being treated for less than a year with an intensified multi-drug cocktail of AIDS
ANALYSIS-'At war time speed', China leads COVID-19 vaccine race
By Sangmi Cha and Miyoung Kim SEOUL/SINGAPORE (Reuters) - China is forging ahead in the race to develop a vaccine to help control the COVID-19 pandemic, with Sinovac Biotech's experimental vaccine set
U.S. FDA alerts on false positive result from Becton Dickinson COVID-19 test
By Reuters Staff (Reuters) - The U.S. Food and Drug Administration alerted clinical laboratories and healthcare providers on Monday about false positive results from one of Becton Dickinson and Co's
U.S. government awards Novavax $1.6 billion for coronavirus vaccine
By Julie Steenhuysen CHICAGO (Reuters) - The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United
EXCLUSIVE-Moderna spars with U.S. scientists over COVID-19 vaccine trials
By Marisa Taylor and Robin Respaut (Reuters) - As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc, one of the
Early screening may curb breast cancer deaths in childhood cancer survivors
By Marilynn Larkin NEW YORK (Reuters Health) - In childhood cancer survivors, starting annual magnetic resonance imaging (MRI) screening at ages 25-30 may reduce breast cancer deaths by at least 50%,
Older hep C patients may remain at risk for HCC even after viral clearance
By Marilynn Larkin NEW YORK (Reuters Health) - Chronic hepatitis C patients ages 75-84 remained at high risk of liver cancer even after direct-acting antivirals (DAAs) cleared the virus, according to
Rise in child head trauma during COVID-19 lockdowns may point to domestic violence spike
By Linda Carroll July 6 (Reuters) - (Reuters Health) - Stresses associated with COVID-19 lockdowns may be fueling increases in domestic violence, British researchers suggest, based on a jump in the
Brief oral steroid bursts raise risk of GI bleeding, sepsis, heart failure
By Megan Brooks NEW YORK (Reuters Health) - A short course of corticosteroids is associated with a 1.8- to 2.4-fold increased risk for gastrointestinal bleeding, sepsis, and heart failure (HF) within
COVID SCIENCE-Inflammation key to severe COVID-19 in high-risk groups; plasma therapy only right for some patients
By Nancy Lapid (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness
Positive autism screening tied to earlier diagnosis
By Lisa Rappaport (Reuters Health) - Children who screen positive for autism at checkups when they're 18 or 24 months old are likely to be diagnosed sooner, when interventions can be more effective at
New York's Cuomo pleads with Trump to acknowledge COVID-19 as 'major problem'
By Reuters Staff (Reuters) - New York Governor Andrew Cuomo on Monday called on President Donald Trump to not be a "co-conspirator" of the coronavirus and acknowledge the "major problem" it poses as
EU looking to ramp-up production of COVID-19 antiviral remdesivir
By Francesco Guarascio BRUSSELS (Reuters) - Germany has only a few hundred doses of COVID-19 antiviral remdesivir, Health Minister Jens Spahn told European Union lawmakers on Monday, saying he was
Life-saving HIV drugs risk running out as COVID-19 hits supplies - WHO
By Reuters Staff LONDON (Reuters) - More than a third of the world's countries say they are at risk of running out of life-saving AIDS drugs because of disruptions to supply lines and other problems
WHO says reviewing NYT article on concerns over airborne spread of COVID-19
By Reuters Staff GENEVA (Reuters) - The World Health Organization (WHO) is reviewing a report that suggested its advice on the novel coronavirus needs updating, after some scientists told the New York
Spanish island trials COVID-19 tracing app that will create virtual outbreak
By Paola Luelmo GRAN CANARIA, Spain (Reuters) - Residents of the Spanish island of La Gomera have started downloading a new app on their phones aimed at stopping the spread of COVID-19 infections in a
Make a vaccine? I'm trying to teach my kids the alphabet
By Kate Holton, Emma Thomasson and Stephen Jewkes LONDON/BERLIN/MILAN (Reuters) - It's tough to do any useful work when you're stuck at home, struggling to home-school bickering kids, let alone when
CureVac nets EU funding to ramp up vaccine production
By Reuters Staff BERLIN (Reuters) - German biotech company CureVac, which is developing a potential COVID-19 vaccine, has secured a 75 million euro ($85 million) loan from the European Investment Bank
Faltering AIDS battle risks 10-year setback from COVID-19, UN warns
By Kate Kelland LONDON (Reuters) - The global fight against AIDS was faltering even before the COVID-19 pandemic, and this newly-emerged viral disease is now threatening to put progress against HIV
Inflammatory bowel disease linked to increased dementia risk
By Anne Harding NEW YORK (Reuters Health) - People with inflammatory bowel disease (IBD) are more than twice as likely to develop dementia, especially Alzheimer's disease (AD), according to a new
Sickle cell disease may not worsen COVID-19 prognosis
By Will Boggs MD NEW YORK (Reuters Health) - Sickle cell disease does not appear to worsen the prognosis of COVID-19, at least not in younger patients, although vaso-occlusive crisis is common with
Tocilizumab therapy tied to better outcomes of severe COVID-19
By Will Boggs MD NEW YORK (Reuters Health) - Tocilizumab therapy is associated with a lower risk of invasive mechanical ventilation or death in patients with severe COVID-19, according to a new study.
Nurses in Zimbabwe arrested as they protest over pay
By Reuters Staff HARARE (Reuters) - Police in Zimbabwe arrested 12 nurses protesting outside state hospitals on Monday demanding to be paid in U.S. dollars as inflation running at nearly 800% was
Regeneron begins COVID-19 antibody cocktail late-stage trial
By Reuters Staff (Reuters) - Regeneron Pharmaceuticals Inc said on Monday it began late-stage clinical trials to assess the effectiveness of its antibody cocktail in preventing and treating COVID-19,
Britain puts $10 million into study on long term effects of COVID-19
By Reuters Staff LONDON (Reuters) - Britain is putting 8.4 million pounds ($10.49 million) into a new study to examine the long-term effects of COVID-19 on patients, the health ministry said on Sunday
Spanish antibody study finds 5% of population exposed to coronavirus
By Reuters Staff MADRID (Reuters) - Results from the final stage of a nationwide antibody study suggest that some 5.2% of Spain's population has been exposed to the new coronavirus, health officials
